Metastin suppresses the motility and growth of CHO cells transfected with its receptor.
Hori. A A; Honda. S S; Asada. M M; Ohtaki. T T; Oda. K K; Watanabe. T T; Shintani. Y Y; Yamada. T T; Suenaga. M M; Kitada. C C; Onda. H H; Kurokawa. T T; Nishimura. O O; Fujino. M M
Key Findings
- Metastin (kisspeptin‑10) blocks cell movement and invasion at 10‑100 nM in CHO cells with its receptor
- Shorter versions of the peptide (40‑54 and 45‑54) work just as well as the full peptide
- Metastin also reduces cell spreading, growth on a surface, and colony formation in agar
Practical Outcomes
- These results are interesting for cancer research but don’t give any direct guidance for human use, dosing, or safety. Biohackers looking for longevity or performance benefits have no actionable protocol to apply from this work.
Summary
The study shows that a short piece of the kisspeptin protein, called metastin, can stop certain hamster cells from moving and growing in lab dishes, but it was only tested in cell cultures, not in people.
Abstract
We recently reported having identified of the ligand for an orphan G-protein-coupled receptor, hOT7T175, as the gene product (68-121)-amide of the metastasis suppressor gene KiSS-1. We further showed that the ligand, which we named "metastin," inhibits chemotaxis and invasion of Chinese hamster ovary (CHO) cells transfected with hOT7T175 cDNA (CHO/h175) in vitro, and pulmonary metastasis of hOT7T175-transfected B16-BL6 melanomas in vivo. In the present study, we investigated the activity of metastin in CHO/h175 cells in greater detail. Metastin significantly suppressed motility in a chemotaxis assay and wound healing assay at 10-100 nM order concentrations. Two N-terminally truncated peptides, metastin(40-54) and metastin(45-54) inhibited the migration of CHO/h175 cells as potently as metastin itself. Metastin also inhibited the spreading, monolayer growth and colony formation in agar (0.8%) of CHO/h175 cells at 10-100 nM concentrations. These results indicate that metastin is a potent inhibitor of cell motility, leading to suppression of cell growth and antimetastatic activity, and suggest that low molecular chemical compounds could replace its activity as a novel antimetastatic agent.
Study Information
pubmed
2001
2001-09-07T00:00:00.000Z
10.1006/bbrc.2001.5470